I

IPCA Laboratories Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 18 analysts offering recommendations for IPCA Laboratories Ltd

72%

Buy

22%

Hold

6%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio67.0150.69
PB Ratio4.756.47
Dividend Yield0.28%0.52%

Understand what these metrics mean. 

About the company

I

IPCA Laboratories Ltd

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions